Baxter International Inc vs Quantum Computing Inc — how do they compare? Baxter International Inc trades at $27.2 (market cap $14.27B), while Quantum Computing Inc trades at $8.95 (market cap $2.03B). The key difference: Baxter International Inc is far larger — about 7× Quantum Computing Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| BAX | QUBT | |
|---|---|---|
Market Cap | $14.27B | $2.03B |
Sector | Health | Technology |
52-Week High | $28.35 | $24.62 |
52-Week Low | $15.80 | $6.31 |
Enterprise Value | $21.79B | $1.09B |
Dividend Yield | 0.14% | — |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $27.09, down 2.48% today but showing strong technical momentum with bullish moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.56, beating expectations by 53%, and raised full-year guidance. Despite negative net margins and elevated P/E ratio of 87.85, improving operational performance and positive cash flow projections for 2026 suggest potential turnaround.
The stock presents a mixed outlook with strong technical momentum and recent operational improvements offset by valuation concerns and profitability challenges. Key opportunities include continued execution on raised guidance and debt reduction efforts, while risks center on margin pressure and high debt levels. Analyst consensus leans neutral with 55.55% hold ratings and $25.43 price target below current levels.
Quantum Computing Inc. (QUBT) trades at $8.91, down 0.22% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 revenue of $5.6 million, a significant increase year-over-year, though it posted a net loss. Analyst sentiment is positive with a 75% buy rating and a consensus price target of $18.50, suggesting substantial upside potential from current levels.
QUBT presents high-risk, high-reward potential as it transitions to commercial scaling, with strong revenue growth offset by persistent losses and negative margins. Key risks include execution challenges in manufacturing expansion and intense competition in the quantum computing sector. The stock's valuation remains steep with a P/S ratio of 189.05, requiring careful monitoring of profitability improvements.
Trailing returns across standard periods
Latest headlines on both assets
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →